Family Offices Govern Every Asset on the Principal's Balance Sheet — Except the One That Produces All the Others
Biology is a measurable system, not a random outcome. Risk inside that system can be quantified, modelled, and governed — using the same discipline applied to capital, exposure, and infrastructure. AMSEL closes the gap.
14 days
Data Window
Per Cycle
50,000+
Documented
Case-Base
40 yrs
Institutional
Methodology
One Cycle · Two Outputs
The clinical data from each BAM cycle is processed twice — producing one institutional output for governance, and one principal-facing output for review. Same signal. Different audiences. Different decisions.
Layer 1 · Clinical Profile
ALRI Composite
Algorithmic composite 0–100. 4 master systems. 13 clinical systems. ARR tier classification. Single headline + trend vector.
Audience · Investment Committee · Institutional Reporting
Layer 2 · Risk Profile
9-Domain Dashboard
Domain risk score 0–100 each. Band A–E per domain. Radar + plain-language descriptors. Identifies where the risk sits.
Audience · Principal · Clinician · Annual Review
ALRI answers how bad overall.
The Risk Profile answers where the risk sits.
Four Risk Categories
Three at Equal Weight, One at Half
The biological equivalent of asset classes. Every system ultimately reports into one of four. Their balance — and the rate at which any one degrades — governs the slope of biological decline. Within each system, each system contributes proportionally based on observed clinical significance and longitudinal outcome data.
28%
SYSTEM
Terrain
The internal environment
Where cells live. Toxic load, detoxification, microbiome, cardiovascular structure.
28%
SYSTEM
Defense
The immune apparatus
Threat detection, inflammation control, immune signalling.
28%
SYSTEM
Energy
Cellular fuel and repair
Metabolic stability, mitochondrial output, hormonal-endocrine signalling.
16%
SYSTEM
Regulation
Command and control
Neurological signal coherence, autonomic balance — the system that governs the other three.
Layer 01 · Observation
The body produces signal continuously. The framework reads it.
D-09
Hormonal & Endocrine
How well the body's signalling system is regulating itself.
Endocrine axis function across thyroid, adrenal, sex hormones, body composition.
FEEDS
Hormonal & Endocrine
Metabolic Stability
Immune Surveillance
Neurological Risk
Hormonal & Endocrine
Metabolic Stability
Immune Surveillance
Neurological Risk
D-08
Biological Reserve
How much margin the body has before any failure cascades.
Buffer depth, regenerative margin, distance to disproportionate failure. Modifies all twelve clinical systems.
FEEDS
Toxic Load
Detoxification Capacity
Microbiome & Gut
Cardiovascular
Oral-Systemic Health
Immune Surveillance
Chronic Inflammation
Cortisol Axis
Metabolic Stability
Mitochondrial Energy
Hormonal & Endocrine
Neurological Risk
Autonomic & Sleep Regulation
Toxic Load
Detoxification Capacity
Microbiome & Gut
Cardiovascular
Oral-Systemic Health
Immune Surveillance
Chronic Inflammation
Cortisol Axis
Metabolic Stability
Mitochondrial Energy
Hormonal & Endocrine
Neurological Risk
Autonomic & Sleep Regulation
D-07
Toxic Load & Environmental
How much accumulated toxic burden the body is carrying.
Heavy metals, biotoxins, air quality, cumulative environmental exposure.
FEEDS
Toxic Load
Detoxification Capacity
D-06
Sleep & Recovery Efficiency
How fully the body repairs itself between cycles.
Sleep architecture, recovery debt, repair-cycle integrity. Risk multiplier across all systems.
FEEDS
Immune Surveillance
Mitochondrial Energy
Toxic Load
Neurological Risk
Immune Surveillance
Mitochondrial Energy
Toxic Load
Neurological Risk
D-05
Autonomic & Stress Load
How well the nervous system shifts down out of stress mode.
HRV recovery, sympathetic / parasympathetic balance, down-regulation capacity.
FEEDS
Immune Surveillance
Chronic Inflammation
Metabolic Stability
Mitochondrial Energy
Neurological Risk
Immune Surveillance
Chronic Inflammation
Metabolic Stability
Mitochondrial Energy
Neurological Risk
FEEDS
D-04
Neurological & Cognitive
How quickly thinking degrades under load — and recovers.
Decision degradation under stress, cognitive recovery slope, signal coherence.
Neurological Risk
Metabolic Stability
Toxic Load
Neurological Risk
Metabolic Stability
Toxic Load
FEEDS
D-03
Metabolic Stability
How well the body runs on its own fuel under stress.
Glucose variability, metabolic flexibility, substrate-switching capacity.
Metabolic Stability
Mitochondrial Energy
Hormonal & Endocrine
Metabolic Stability
Mitochondrial Energy
Hormonal & Endocrine
FEEDS
D-02
Oral–Systemic Risk
How much hidden inflammation is leaking from the mouth.
Persistent oral inflammatory load with systemic spillover into immune and microbiome terrain.
Chronic Inflammation
Immune Surveillance
Microbiome & Gut
Microbiome & Gut
Chronic Inflammation
Immune Surveillance
FEEDS
D-01
Movement & Physical Optionality
How freely the body still moves under load.
Compensation patterns, fatigue asymmetry, mechanical reserve under load.
Mitochondrial Energy
Chronic Inflammation
Cardiovascular Architecture
Mitochondrial Energy
Chronic Inflammation
Cardiovascular Architecture
FEEDS
Terrain · 28%
DEFENSE · 28%
ENERGY · 28%
REGULATION · 16%
The framework is not a 9-to-4 mapping — it is a many-to-many graph. Each functional system produces its own read and feeds 1–12 clinical systems via cross-system logic. The interaction profile, not single readings, governs the composite.
Nine Systems · Each Feeds Multiple Clinical Systems
Layer 02 · Measurement
Every biomarker is processed under accredited laboratory protocol. Collected, never estimated; analysed, never self-reported.
Thirteen Clinical Systems
The Translated Exposures
Where Layer 01 observes function, Layer 02 measures biology directly. Thirteen clinical systems, organised under the four master systems. Plain meaning first; biomarker panel and mechanistic context follow.
Terrain · 28% · 5 systems
Toxic Load
Accumulated toxic burden.
Pb · Hg · Cd · Al · BPA · PFAS
Toxins interfere with mitochondrial function, immune signalling, and glymphatic clearance. Neurotoxic burden accumulates silently and accelerates neurodegeneration 15–20 years before clinical presentation.
Microbiome & Gut
Gut ecosystem and barrier integrity.
Bacteroides · sIgA · Zonulin · Calprotectin
Gut dysfunction drives systemic inflammation and receives seeding from oral dysbiosis. Leaky gut (elevated Zonulin) is a primary terrain failure mode — the body's interior becoming permeable to inflammatory triggers.
Oral-Systemic Health
Oral cavity as systemic risk driver.
Periopath PCR · Salivary pH · Clinical Oral Score · Mercury vapor
New in v2.0 under Dr. Kanchirat Luangaram DDS. Periodontal pathogens (P. gingivalis, T. denticola, T. forsythia) drive carotid IMT progression, T2DM, Alzheimer's, and adverse pregnancy outcomes. The oral cavity is a primary source of systemic bacterial load and a regulation blockage per Dr. Rau's biological medicine framework.
Detoxification Capacity
How well the body clears that burden.
Glutathione · MTHFR · Homocysteine · Cystatin-C
Two patients with identical toxic exposure can have radically different biological outcomes based on detox capacity. MTHFR status governs methylation — the master switch for gene expression, DNA repair, and neurotransmitter synthesis.
Cardiovascular Architecture
Vascular structure and aerobic capacity.
Lp(a) · ApoB · hs-Troponin · VO₂ max
Cardiovascular disease is the leading global cause of mortality. Lp(a) is genetically fixed and must be known. ApoB is the true atherogenic particle count — superior to LDL-C. VO₂ max is the strongest single longevity predictor in the epidemiological literature.
Defense · 28% · 3 systems
Immune Surveillance
Active immune readiness.
NK cells · CD4 / CD8 · IL-6 · TNF-α
Detects immune exhaustion and chronic activation. NK cell decline is an early signal of immune senescence — the progressive failure of immune defence capacity with biological age.
Cortisol Axis
Stress-hormone regulation.
Cortisol AM / PM · DHEA-S
Cortisol is the primary immunomodulator. Chronic elevation drives immune suppression, gut permeability, and metabolic instability simultaneously. DHEA-S decline marks adrenal aging and immune vulnerability.
Chronic Inflammation
Background inflammatory burden.
hs-CRP · IL-6 · Ferritin
Common denominator of aging diseases — cancer, cardiovascular, neurological. Chronic low-grade inflammation is the mechanism by which terrain compromise and energy depletion become clinically expressed disease.
Energy · 28% · 3 systems
Metabolic Stability
Glucose-insulin handling.
HbA1c · Fasting Insulin · HOMA-IR · IGF-1
Metabolic dysregulation is the foundation of many chronic diseases. Glucose volatility directly impairs decision speed, working memory, and mitochondrial efficiency — making this a convergence point for energy and regulation signals.
Hormonal & Endocrine
Endocrine signalling at full panel.
TSH · Free T3 / T4 · Testosterone · Estradiol
Hormones are the master regulators of all three other systems. Thyroid governs whole-body metabolic rate; testosterone governs muscle, metabolic health, and cognitive drive; estradiol modulates microbiome, bone, vascular terrain, and immune regulation.
Mitochondrial Energy
Cellular energy production.
Lactate · Pyruvate · CoQ10 · NAD+ / NADH
Almost never tested in standard clinical settings. Determines repair rate, recovery speed, and the pace of biological aging. Mitochondrial output sets the ceiling for what defence and terrain can achieve.
Regulation · 16% · 2 systems
Neurological Risk
Brain-resilience signal.
APOE · Neuroinflammation · Homocysteine · BDNF
Neurological risk is a cross-system signal — it reflects toxic terrain (heavy metals are neurotoxic), immune-driven neuroinflammation, and mitochondrial failure simultaneously. Predicts cognitive decline 15–20 years before diagnosis.
Autonomic Coherence
Stress-recovery capacity.
HRV (RMSSD / SDNN) · LF / HF ratio
Measures the nervous system's capacity to modulate between sympathetic activation and parasympathetic recovery. Its decline precedes and amplifies failure in all three other master systems.
Compounding Interactions · The Moat
A single biomarker has limited explanatory power. The framework's value sits at the intersection — where two or more systems compound. Below: observed correlations classified by strength. This is the IP layer of the system.
CRITICAL
Autonomic × Cognitive
Neurological risk is a cross-system signal — it reflects toxic terrain (heavy metals are neurotoxic), immune-driven neuroinflammation, and mitochondrial failure simultaneously. Predicts cognitive decline 15–20 years before diagnosis.
CRITICAL
Sleep × Metabolic × Autonomic
Sleep inconsistency simultaneously increases metabolic load, HRV suppression, and cortisol dysregulation
CRITICAL
Biological Reserve × All Domains
Reduced buffer depth magnifies the impact of every other domain
CRITICAL
Hormonal × Metabolic × Neurological [7]
Thyroid decline suppresses metabolic rate; testosterone decline impairs insulin sensitivity; estrogen loss increases neuroinflammation risk
HIGH
Metabolic × Neurological [7]
Glucose volatility directly impairs decision speed and working memory recovery
HIGH
Sleep × Neurological × Toxic Load [6]
Glymphatic clearance during sleep removes amyloid and tau — sleep debt is accumulated neurotoxic burden
HIGH
Movement × Cardiovascular × Autonomic
Physical asymmetry under fatigue elevates autonomic load and reduces cardiovascular reserve
HIGH
Oral-Systemic × Microbiome
Oral dysbiosis is the proximal source of gut dysbiosis — persistent oral inflammation seeds systemic terrain failure
HIGH
Cortisol (Hormonal) × Immune × Metabolic [8]
Chronic cortisol elevation drives immune suppression, gut permeability, and glucose dysregulation simultaneously
Anchored References in Section 08 · Full Evidence Base at /Evidence
Layer 03 · Compounding
Risk lives in interaction. Mitochondrial output sets the ceiling for what every other system can achieve.
The Global Modifier · Read Before ALRI
Reserve is not a separate layer — it is the variable that modifies every other layer. It defines how much insult the system can absorb before a single-system failure becomes a multi-system cascade.
Operating Definition
Reserve is the buffer between current function and maximum biological capacity.
-
Acts as a composite modifier across all nine biological systems and all twelve clinical systems.
-
High reserve absorbs single-system variance without cascading.
-
Depleted reserve produces disproportionate decline from any single-system hit.
-
Reserve is the variable the framework is designed to defend over time.
Reserve as a Score Modifier
Reserve applies as a multiplier on the raw ALRI composite. When Reserve is adequate, the score is unmodified. As Reserve depletes, the modifier reduces the final score — compressing the apparent safety margin and, in depletion scenarios, reclassifying the composite band entirely.
The Equation
ALRIfinal = ALRIraw × Rmodifier
Worked Example
Raw ALRI
68
Band C · Moderate
Reserve Score
32
Significant Depletion
Final ALRI
57.8
Band D · Elevated
68 × 0.85 = 57.8 → Reserve deficit reclassifies the composite from Moderate to Elevated.
The Reserve modifier and its contribution are disclosed in the system decomposition at every recalibration cycle.
Reserve Composition Note
The Mitochondrial sub-component of Reserve was reformulated in the Tier 3 specification. The original two-marker composition (CoQ10 50% + NAD+/NADH 50%) was revised to NAD+/NADH 70% + GDF-15 30%. CoQ10 is retained as a clinical marker in the Mitochondrial system but is no longer carried inside the Reserve formula itself. The change reflects current evidence weighting; CoQ10 remains available as a longitudinal mitochondrial marker outside the Reserve composite.
Cardiovascular · Cycle-Cadence Note
Ambulatory Blood Pressure Monitoring (ABPM) — the 24-hour reading that captures nocturnal dip — is conducted at baseline only. In subsequent cycles, the Cardiovascular Architecture (C-04) blood-pressure composite redistributes the ABPM weight across resting systolic and diastolic measurements. The cycle-on-cycle cardiovascular score remains comparable; the baseline ABPM contribution is held constant as a reference and does not re-enter the running composite.
Where reserve hides — and matters
Cardiac Capacity
30–40% utilised at rest. The remaining 60% is the reserve — the buffer against acute load.
Alzheimer's Pathology
Begins 15–20 years before symptomatic presentation. ~60% of neuronal capacity is lost by clinical diagnosis.
Pulmonary Function
Up to 50% loss is symptomatically silent — measurable only against historical reserve.
Endocrine Reserve
Testosterone and DHEA-S decline begins in the 30s. Clinically silent until 40–60% loss.
Mitochondrial Reserve
CoQ10 and NAD+ depletion precedes fatigue, cognitive degradation, and immune failure by years.
Pre-clinical Horizon
By the time pathology is diagnosable, capacity has already been lost. Reserve is the variable that determined the gap.
Selected References Underneath the Framework
Foundation
[1] Sonnenberg methodology
[2] 50,000+ documented case-base
TERRAIN
[4] Cardiovascular
Mensink R et al. Effects of saturated fatty acids on serum lipids and lipoproteins: a meta-analysis. Eur J Clin Nutr, 2003.
[10] Cardiovascular Architecture (VO₂ max)
Ross R et al. Importance of assessing cardiorespiratory fitness in clinical practice. Circulation. 2016;134(24):e653–e699. PMID: 27881567.
[11] Cardiovascular Architecture (APOB)
Sniderman AD et al. The causal exposure to apolipoprotein B in atherosclerotic cardiovascular disease. JAMA Cardiol. 2022;7(6):587–592.
DEFENSE
[3] Immune Surveillance
Liu C-J et al. The role of NK cells in immune senescence. Aging Cell, 2021. PMID: 34031954.
[8] Cortisol × Immune × Metabolic
Chrousos GP. Stress and disorders of the stress system. Nat Rev Endocrinol. 2009;5(7):374–381. PMID: 19488073.
ENERGY
[7] Metabolic × Neurological (glucose volatility)
Crane PK et al. Glucose levels and risk of dementia. N Engl J Med. 2013;369(6):540–548. PMID: 23924004.
[13] Mitochondrial Energy (NAD+ / COQ10)
Yoshino J et al. NAD+ intermediates: the biology and therapeutic potential of NMN and NR. Cell Metab. 2018;27(3):513–528.
Regulation
[5] Neurological Risk
Kaufmann T et al. Common brain disorders are associated with heritable patterns of apparent aging. Nature Neuroscience, 2019.
[6] Sleep × Neurological × Toxic Load (glymphatic clearance)
Xie L et al. Sleep drives metabolite clearance from the adult brain. Science. 2013;342(6156):373–377. PMID: 24136970.
[9] Autonomic Coherence (HRV)
Task Force, European Society of Cardiology. Heart rate variability: standards of measurement. Circulation. 1996;93(5):1043–1065. PMID: 8598068.
[12] Neurological Risk (APOE)
Corder EH et al. Gene dose of apolipoprotein E type 4 allele and the risk of Alzheimer's disease in late onset families. Science. 1993;261(5123):921–923. PMID: 8346443.
See full Evidence Base at /Evidence
What the Framework Qualifies — And Where the Literature is in Motion
Institutional rigor requires that we surface — not bury — the limits of every contested marker. The disclosures below are operational, not promotional.
MD-01
hs-Troponin · Cardiovascular Architecture (C-04)
Weight reduced to 10% within the cardiovascular system. The marker has strong evidence in symptomatic populations but limited longitudinal monitoring data in asymptomatic principals. Carried as a supporting marker pending stronger evidence.
MD-03
Zonulin · Microbiome & Gut (C-03)
Weight reduced from 30% to 25% pending commercial assay validation. Multiple ELISA platforms produce inconsistent results. I-FABP cited as an alternative gut-permeability marker; review is ongoing.
MD-05
Outcome Claim · Indicative, Not Validated
Any improvement projection (e.g. "+15 ALRI over 4 cycles") is indicative, derived from clinical modelling on the institutional reference cohort. AMSEL has no prospective outcome data. A formal validation study is in development.
MD-02
LF/HF Ratio · Autonomic Coherence (C-12)
Included as one of multiple HRV markers, not the primary. Scientific consensus has revised its interpretation since 1996; the ratio is no longer treated as a clean sympathovagal balance metric. RMSSD and SDNN carry the structural weight in this system.
MD-04
MTHFR · Detoxification Capacity (C-02)
Repositioned to a 2% conditional modifier on the Homocysteine weight. Compound heterozygous (677T+1298C) or homozygous 677T status increases the Homocysteine weight by 5% within the system. MTHFR is not used as a standalone diagnostic score.
MD-06
Sonnenberg Attribution
AMSEL operates on the institutional Sonnenberg case-base. The methodology was refined in collaboration with the BioMed Center Sonnenberg clinical team — not separately developed by AMSEL. The framework is a translation layer, not a parallel system.
Framework Status
The AMSEL BAM framework is an evidence-informed clinical hypothesis. Domain weights, threshold curves, and the Reserve modifier are derived from peer-reviewed literature and the institutional Sonnenberg case-base. No prospective outcome study has yet been conducted. Validation is in development.
Biology is Your Most Consequential Asset · Now it Can Be Governed
Nine underlying positions. Twelve translated exposures. Four risk categories — weighted, governed, and recalibrated on a fixed cadence. One composite portfolio read.
Reserve as the buffer that determines how much any single position can move before the entire stack is at risk. Cross-system compounding made visible. Pre-clinical risk quantified 5–20 years before any single organ shows symptomatic decline.
The same discipline a family office applies to its capital stack — applied to the asset that produces every other asset.